Check category
Chronological Order:
Pharma Tech Outlook Names HiRO as Top 10 CROs in APAC 2022
Read more >>
Led by OrbiMed, HiRO Raised Tens of Millions of US Dollars in Series A Financing, to Offer Multinational Global Clinical Development Strategy
HiRO announced the completion of its Series A financing in the tens of millions of US dollars. This round of investment is led by OrbiMed, with the participation from existing shareholder, Fontus Capital.
Read more >>
PKU and HiRO Are Partnering to Bring Medicine to Patients, Faster and Successfully.
Read more >>
HiRO completes the acquisition of PharmaSols, expands its coverage in the Asia-Pacific region, improves clinical operation capabilities and international layout
HiRO's acquisition of Pharmaceutical Solutions (PharmaSols or PSL), an agreement was formally signed in October 2021.
Read more >>
HiRO and CluePoints have reached a strategic cooperation to provide the most advanced RBQM expertise and services in the Chinese market
HiRO and CluePoints signed a partnership agreement to provide HiRO clients state-of-the-art Risk-Based Quality Management (RBQM) expertise and technical services in Greater China.
Read more >>
Previous page
1
Next page
×
搜索
Tel：+86 21 62191220
Email ：info@harvestiro.com
Add：33C2, Zhongyi Building,
No. 580 Nanjing West Road, Shanghai
Copyright © 2022 Harvest Integrated Research Organization 沪ICP备2021009006号
×
-
-
-
Contact information
Service hours:9:00 — 18:00
Contact number:
-
